Skip to content

A.CATRIN PHARMA: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

A.CATRIN PHARMA

BE 1007.709.640
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€16,184
2024 · €8,960+€7,224
Equity
€27,311
2024 · €11,960+€15,351
Cash
€44,943
2024 · €13,771+€31,171
Balance sheet total
€94,339
2024 · €23,984+€70,356

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€34,133

    up €34,133 (+455.7%), from €7,490 to €41,623

    of which Furniture and vehicles: +€34,014

  • Cash +€31,171

    up €31,171 (+226.4%), from €13,771 to €44,943

    mainly Other debts (+€47,126) and Net result for the year (+€16,184)

  • Receivables within one year +€3,940

    up €3,940 (+144.7%), from €2,723 to €6,662

  • Deferred charges and accrued income +€1,112

    new in 2025: €1,112

Equity and liabilities
  • Other debts +€47,126

    up €47,126 (+605.0%), from €7,790 to €54,916

  • Profit (loss) carried forward +€15,351

    up €15,351 (+171.3%), from €8,960 to €24,311

  • Tax, wage and social debts +€7,833

    up €7,833 (+209.5%), from €3,738 to €11,571

Income statement
  • Gross operating margin +€18,012

    up €18,012 (+150.8%), from €11,945 to €29,956

  • Depreciation +€7,318

    up €7,318 (+1819.5%), from €402 to €7,720

  • Taxes +€2,752

    up €2,752 (+122.4%), from €2,249 to €5,001

  • Other operating charges +€753

    up €753 (+335.2%), from €225 to €978

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €8,960
Gross operating margin +€18,012
Depreciation -€7,318
Other operating charges -€753
Financial income +€0
Financial charges +€36
Taxes -€2,752
Result 2025 €16,184

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€73,857
Investment -€41,852
Financing -€833
Cash 2024 €13,771
Net result for the year +€16,184
Depreciation +€7,720
Receivables within one year -€3,940
Deferred charges and accrued income -€1,112
Trade debts +€45
Tax, wage and social debts +€7,833
Other debts +€47,126
Investment in fixed assets (net) -€41,852
Contributions, distributions and other -€833
Cash 2025 €44,943
Every line side by side 34 lines
Line Code 2024 2025 Change %
Total assets 20/58 €23,984 €94,339 +€70,356 +293.3%
Fixed assets 21/28 €7,490 €41,623 +€34,133 +455.7%
Tangible fixed assets 22/27 €7,490 €41,623 +€34,133 +455.7%
Land and buildings 22 €7,490 €5,912 -€1,579 -21.1%
Plant, machinery and equipment 23 - €1,697 +€1,697
Furniture and vehicles 24 - €34,014 +€34,014
Current assets 29/58 €16,494 €52,717 +€36,223 +219.6%
Amounts receivable within one year 40/41 €2,723 €6,662 +€3,940 +144.7%
Trade receivables 40 €2,723 €6,662 +€3,940 +144.7%
Cash at bank and in hand 54/58 €13,771 €44,943 +€31,171 +226.4%
Deferred charges and accrued income 490/1 - €1,112 +€1,112
Total equity and liabilities 10/49 €23,984 €94,339 +€70,356 +293.3%
Equity 10/15 €11,960 €27,311 +€15,351 +128.4%
Contributions 10/11 €3,000 €3,000 = 0.0%
Profit (loss) carried forward 14 €8,960 €24,311 +€15,351 +171.3%
Amounts payable 17/49 €12,024 €67,028 +€55,004 +457.5%
Amounts payable within one year 42/48 €12,024 €67,028 +€55,004 +457.5%
Trade debts 44 €496 €541 +€45 +9.2%
Suppliers 440/4 €496 €541 +€45 +9.2%
Taxes, remuneration and social security 45 €3,738 €11,571 +€7,833 +209.5%
Taxes 450/3 €3,738 €11,571 +€7,833 +209.5%
Other amounts payable 47/48 €7,790 €54,916 +€47,126 +605.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €402 €7,720 +€7,318 +1819.5%
Other operating charges 640/8 €225 €978 +€753 +335.2%
Gross operating margin 9900 €11,945 €29,956 +€18,012 +150.8%
Operating profit (loss) 9901 €11,318 €21,258 +€9,941 +87.8%
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B €109 €73 -€36 -32.9%
Recurring financial charges 65 €109 €73 -€36 -32.9%
Profit (loss) for the period before taxes 9903 €11,209 €21,185 +€9,976 +89.0%
Income taxes 67/77 €2,249 €5,001 +€2,752 +122.4%
Profit (loss) for the period 9904 €8,960 €16,184 +€7,224 +80.6%
Profit (loss) for the period to be appropriated 9905 €8,960 €16,184 +€7,224 +80.6%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.